MDGEFMediGene AG

About MediGene AG (MDGEF)

MediGene AG (MDGEF) is a Biotechnology company headquartered in Planegg-Martinsried, Germany whose shares trade over-the-counter on the Pink tier.

Medigene is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene concentrates on the development of personalized T cell immunotherapies with a focus on haematological malignancies. Medigene is the first German biotech company to have revenues from a marketed product, which is distributed by commercial partner companies. Medigene has advanced drug candidates which are licensed to partners and additional candidates in clinical development. The company is developing highly innovative treatment platforms concentrating on cancer and autoimmune diseases.

MDGEF key facts

Ticker symbol

MDGEF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Planegg-Martinsried, Germany

Country of incorporation

DE

Employees

71

Shares outstanding

24,865,429

Reporting standard

International Reporting: Frankfurt Stock Exchange

Audit status

Audited

Fiscal year end

12/31

MediGene AG leadership

• Peter Heinrich — CEO
• Peter Llewellyn Davies — CFO

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with M